A detailed history of Nomura Asset Management CO LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Nomura Asset Management CO LTD holds 1,082,758 shares of ABBV stock, worth $179 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares
1,082,758
Previous 979,168 10.58%
Holding current value
$179 Million
Previous $168 Million 27.32%
% of portfolio
0.67%
Previous 0.58%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$163.84 - $199.33 $17 Million - $20.6 Million
103,590 Added 10.58%
1,082,758 $214 Million
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $3.54 Million - $4.13 Million
22,849 Added 2.39%
979,168 $168 Million
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $2.31 Million - $2.63 Million
-14,435 Reduced 1.49%
956,319 $174 Million
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $1.77 Million - $2 Million
12,895 Added 1.35%
970,754 $150 Million
Q3 2023

Nov 03, 2023

BUY
$133.59 - $154.65 $8.78 Million - $10.2 Million
65,758 Added 7.37%
957,859 $143 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $6.8 Million - $8.46 Million
51,320 Added 6.1%
892,101 $120 Million
Q1 2023

May 11, 2023

BUY
$144.61 - $166.54 $4.5 Million - $5.18 Million
31,108 Added 3.84%
840,781 $134 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $6.32 Million - $7.58 Million
-45,695 Reduced 5.34%
809,673 $131 Million
Q3 2022

Nov 10, 2022

BUY
$134.21 - $153.93 $21.4 Million - $24.5 Million
159,480 Added 22.92%
855,368 $115 Million
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $2.16 Million - $2.75 Million
-15,708 Reduced 2.21%
695,888 $107 Million
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $3.8 Million - $4.71 Million
-28,788 Reduced 3.89%
711,596 $115 Million
Q4 2021

Feb 01, 2022

BUY
$107.43 - $135.93 $10.4 Million - $13.2 Million
97,243 Added 15.12%
740,384 $100 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $6.46 Million - $7.33 Million
-60,691 Reduced 8.62%
643,141 $69.4 Million
Q2 2021

Aug 06, 2021

BUY
$105.21 - $117.21 $1.65 Million - $1.84 Million
15,704 Added 2.28%
703,832 $79.3 Million
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $2.12 Million - $2.33 Million
-20,702 Reduced 2.92%
688,128 $74.5 Million
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $7.59 Million - $10.3 Million
94,333 Added 15.35%
708,830 $76 Million
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $2.71 Million - $3.18 Million
31,519 Added 5.41%
614,497 $53.8 Million
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $5.39 Million - $7.21 Million
73,445 Added 14.41%
582,978 $57.2 Million
Q1 2020

May 14, 2020

BUY
$64.5 - $97.79 $3.86 Million - $5.85 Million
59,835 Added 13.31%
509,533 $38.8 Million
Q4 2019

Feb 13, 2020

BUY
$72.13 - $90.25 $857,553 - $1.07 Million
11,889 Added 2.72%
449,698 $39.8 Million
Q3 2019

Nov 13, 2019

BUY
$62.98 - $75.72 $2.97 Million - $3.57 Million
47,190 Added 12.08%
437,809 $33.2 Million
Q2 2019

Aug 13, 2019

BUY
$65.7 - $83.98 $633,939 - $810,323
9,649 Added 2.53%
390,619 $28.4 Million
Q1 2019

May 10, 2019

BUY
$77.14 - $90.79 $301,771 - $355,170
3,912 Added 1.04%
380,970 $30.7 Million
Q4 2018

Feb 12, 2019

BUY
$77.85 - $96.01 $1.13 Million - $1.39 Million
14,520 Added 4.01%
377,058 $34.8 Million
Q3 2018

Nov 07, 2018

BUY
$88.91 - $98.84 $1.25 Million - $1.39 Million
14,040 Added 4.03%
362,538 $34.3 Million
Q2 2018

Aug 03, 2018

SELL
$89.78 - $106.23 $636,091 - $752,639
-7,085 Reduced 1.99%
348,498 $32.3 Million
Q1 2018

May 14, 2018

BUY
$92.01 - $123.21 $2.59 Million - $3.47 Million
28,125 Added 8.59%
355,583 $33.7 Million
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $1.6 Million - $1.76 Million
-17,899 Reduced 5.18%
327,458 $31.7 Million
Q3 2017

Nov 13, 2017

SELL
$69.85 - $89.22 $5.77 Million - $7.36 Million
-82,542 Reduced 19.29%
345,357 $30.7 Million
Q2 2017

Aug 14, 2017

BUY
N/A
427,899
427,899 $31 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.